A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
- KATH inaugurates Antimicrobial Stewardship Committee to stem microbial resistanceon November 28, 2021 at 5:27 pm
The Komfo Anokye Teaching Hospital (KATH) in Kumasi has inaugurated the Antimicrobial Stewardship Committee with a call on the members ...
- Aster Medcity gets Center of Excellence in Antimicrobial Stewardship designation from IDSAon November 25, 2021 at 2:40 am
Aster Medcity has been conferred by the Infectious Diseases Society of America (IDSA) with the Center of Excellence title in Antimicrobial Stewardship. The programme recognizes institutions that have ...
- Youth Wing of Amritanandamayi Math Organises Bicycle Rally to Create Awareness on Antimicrobial Resistanceon November 24, 2021 at 8:45 pm
Hyderabad: AYUDH, the youth wing of Mata Amritanandamayi Math, has organised a bicycle rally, with the theme of “Cycle Against AMR—Go Blue”, in the city recently to create awareness among the public ...
- Antimicrobial Textiles Market Sharing Economy in Market Outlook: Big Things are Happeningon November 23, 2021 at 1:28 am
By employing an in depth analysis of the market global Antimicrobial Textiles Market report helps to reap the benefits to win the competition The report has market analysis by locales particularly ...
- Novel carbon dots exhibit antimicrobial activity against gram-negative bacteriaon November 22, 2021 at 3:47 pm
Researchers synthesize carbon dots using different precursors and studied their antimicrobial effects in gram-negative bacteria.
- New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseaseson November 22, 2021 at 4:16 am
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the publication of its Improving Outcomes and Antibiotic Stewardship (IOAS) Study in the journal Clinical Infectious Diseases. The ...
- Accelerate Pheno System Study Published In Clinical Infectious Diseaseson November 22, 2021 at 3:39 am
Accelerate Diagnostics Inc. (AXDX) announced the publication of its Improving Outcomes and Antibiotic Stewardship Study in the journal Clinical Infectious Diseases. The company noted that the ...
- Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care (ASPIC)on November 17, 2021 at 4:00 pm
The association between increase of antibiotics consumption and resistance emergence has been well documented for all patients admitted to the Intensive care unit (ICU) who received antibiotic ...
- PWUD discharged to skilled nursing facilities often do not complete OPATon November 16, 2021 at 7:50 am
Many people who use drugs who are sent to skilled nursing facilities for outpatient parenteral antibiotic therapy do not complete treatment, according to findings from a single-center study published ...
via Bing News